Correction: Current status of therapeutic monoclonal antibodies against SARS-CoV-2.

Correction: Current status of therapeutic monoclonal antibodies against SARS-CoV-2.

[This corrects the article DOI: 10.1371/journal.ppat.1009885.].

Bibliographic Details
Main Authors:	Sanjeev Kumar, Anmol Chandele, Amit Sharma
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2022-11-01
Series:	PLoS Pathogens
Online Access:	https://doi.org/10.1371/journal.ppat.1010983

Similar Items

Current status of therapeutic monoclonal antibodies against SARS-CoV-2.
by: Sanjeev Kumar, et al.
Published: (2021-09-01)

Correction: Current status of therapeutic monoclonal antibodies against SARS-CoV-2
Published: (2022-11-01)

Profiles of host immune impairment in Plasmodium and SARS-CoV-2 infections
by: Rini Chaturvedi, et al.
Published: (2022-12-01)

Broadly Neutralizing Antibodies to SARS-CoV-2 Provide Novel Insights Into the Neutralization of Variants and Other Human Coronaviruses
by: Prashant Bajpai, et al.
Published: (2022-06-01)

Monoclonal Antibodies against SARS-CoV-2: Current Scenario and Future Perspectives
by: Eugenia Quiros-Roldan, et al.
Published: (2021-12-01)

Development of human monoclonal antibodies against SARS-CoV-2
by: Wong, Joel Xu En
Published: (2021)

Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2
by: Jiajia Xie, et al.
Published: (2021-08-01)

In-Silico Analysis of Monoclonal Antibodies against SARS-CoV-2 Omicron
by: Ye-Fan Hu, et al.
Published: (2022-02-01)

Development of novel monoclonal antibodies against nsp12 of SARS-CoV-2
by: Mitsuhiro Machitani, et al.
Published: (2022-12-01)

Light chain of a public SARS-CoV-2 class-3 antibody modulates neutralization against Omicron
by: Anamika Patel, et al.
Published: (2023-09-01)

Characterization of a Broadly Neutralizing Monoclonal Antibody against SARS-CoV-2 Variants
by: Tasnim Saifudin Zakir, et al.
Published: (2022-01-01)

Efficacy of the combination of monoclonal antibodies against the SARS-CoV-2 Beta and Delta variants.
by: Chatikorn Boonkrai, et al.
Published: (2023-01-01)

38227 Specific and highly potent human monoclonal antibodies against SARS-CoV-2
by: Mayara Garcia de Mattos Barbosa, et al.
Published: (2021-03-01)

Monoclonal antibody pairs against SARS-CoV-2 for rapid antigen test development.
by: Nol Salcedo, et al.
Published: (2022-03-01)

Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 omicron sub-lineages
by: Franck Touret, et al.
Published: (2023-04-01)

Evaluation of strategies to modify Anti-SARS-CoV-2 monoclonal antibodies for optimal functionality as therapeutics
by: Robert V. House, et al.
Published: (2022-01-01)

Evaluation of strategies to modify Anti-SARS-CoV-2 monoclonal antibodies for optimal functionality as therapeutics.
by: Robert V House, et al.
Published: (2022-01-01)

Collection of Monoclonal Antibodies Targeting SARS-CoV-2 Proteins
by: Marina Pribanić Matešić, et al.
Published: (2022-02-01)

Monoclonal antibodies binding data for SARS-CoV-2 proteins
by: Nawneet Mishra, et al.
Published: (2022-08-01)

ZRC3308 Monoclonal Antibody Cocktail Shows Protective Efficacy in Syrian Hamsters against SARS-CoV-2 Infection
by: Pragya D. Yadav, et al.
Published: (2021-12-01)

Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV
by: Wen Jiang, et al.
Published: (2021-01-01)

Monoclonal Antibodies against Nucleocapsid Protein of SARS-CoV-2 Variants for Detection of COVID-19
by: Ruei-Min Lu, et al.
Published: (2021-11-01)

Mapping monoclonal anti-SARS-CoV-2 antibody repertoires against diverse coronavirus antigens
by: Matheus Oliveira de Souza, et al.
Published: (2022-09-01)

Mapping monoclonal anti-SARS-CoV-2 antibody repertoires against diverse coronavirus antigens
by: DeKosky, Brandon J.
Published: (2022)

Susceptibility of SARS-CoV-2 Omicron Variants to Therapeutic Monoclonal Antibodies: Systematic Review and Meta-analysis
by: Kaiming Tao, et al.
Published: (2022-08-01)

Dissecting strategies to tune the therapeutic potential of SARS-CoV-2–specific monoclonal antibody CR3022
by: Caroline Atyeo, et al.
Published: (2021-01-01)

Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy
by: Ragonnet-Cronin, M, et al.
Published: (2023)

SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19
by: Kreuzberger, N, et al.
Published: (2021)

SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19
by: Hirsch, C, et al.
Published: (2021)

Safety of Monoclonal Antibodies in Children Affected by SARS-CoV-2 Infection
by: Lorenza Romani, et al.
Published: (2022-03-01)

Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy
by: Manon Ragonnet-Cronin, et al.
Published: (2023-06-01)

Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline
by: Marco Tuccori, et al.
Published: (2020-01-01)

Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection
by: Yu-Chyi Hwang, et al.
Published: (2022-01-01)

A human monoclonal antibody blocking SARS-CoV-2 infection
by: Chunyan Wang, et al.
Published: (2020-05-01)

Investigating the Current Status of SARS-CoV-2 Antibodies in Hospital Staff
by: Keh-Sen Liu, et al.
Published: (2023-05-01)

Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection
by: Sandro Halwe, et al.
Published: (2021-07-01)

Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron variant of concern
by: Fulvia Mazzaferri, et al.
Published: (2022-11-01)

The Therapeutic Monoclonal Antibody Bamlanivimab Does Not Enhance SARS-CoV-2 Infection by FcR-Mediated Mechanisms
by: Robert W. Cross, et al.
Published: (2023-11-01)

Immune escape of SARS-CoV-2 variants to therapeutic monoclonal antibodies: a system review and meta-analysis
by: Huichun Shi, et al.
Published: (2023-11-01)

Monoclonal Antibodies Specific for SARS-CoV-2 Spike Protein Suitable for Multiple Applications for Current Variants of Concern
by: Mahali S. Morgan, et al.
Published: (2022-12-01)